Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
TLRY Tilray Inc
- Stocks
- Healthcare
- NASDAQ: TLRY
Price (delayed)
$0.4424
Market cap
$445.27M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.05
Enterprise value
$589.23M
Tilray is a Canadian pharmaceutical and cannabis company, incorporated in the United States with primary operations headquartered in Toronto, Ontario. Tilray also has operations in Australia, New Zealand, Germany, Portugal,
Highlights
Tilray's quick ratio has increased by 40% YoY and by 2.3% from the previous quarter
The debt has contracted by 29% YoY and by 8% from the previous quarter
TLRY's net income has plunged by 161% YoY
The EPS has dropped by 139% year-on-year
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: https://www.tilray.com/
Key stats
What are the main financial stats of TLRY
Market
Valuations
Earnings
Shares outstanding
1.01B
Market cap
$445.27M
Enterprise value
$589.23M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.15
Price to sales (P/S)
0.49
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.71
Revenue
$826.66M
Gross profit
$255.29M
Operating income
-$854.25M
Net income
-$949.79M
EBIT
-$937.85M
EBITDA
-$806.71M
Free cash flow
-$79.21M
Per share
Balance sheet
Liquidity
EPS
-$1.05
EPS diluted
-$1.05
Free cash flow per share
-$0.09
Book value per share
$2.91
Revenue per share
$0.91
TBVPS
$1.38
Total assets
$3.4B
Total liabilities
$701.04M
Debt
$343.91M
Equity
$2.73B
Working capital
$424.12M
Debt to equity
0.13
Current ratio
2.62
Quick ratio
1.34
Net debt/EBITDA
-0.18
Margins
Efficiency
Dividend
EBITDA margin
-97.6%
Gross margin
30.9%
Net margin
-114.9%
Operating margin
-103.3%
Return on assets
-23.6%
Return on equity
-28.9%
Return on invested capital
-78.8%
Return on capital employed
-29.9%
Return on sales
-113.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TLRY stock price
How has the Tilray stock price performed over time
Intraday
-1.03%
1 week
-10.63%
1 month
0.48%
1 year
-75.83%
YTD
-66.74%
QTD
-32.71%
Financial performance
How have Tilray's revenue and profit performed over time
Revenue
$826.66M
Gross profit
$255.29M
Operating income
-$854.25M
Net income
-$949.79M
Gross margin
30.9%
Net margin
-114.9%
The operating margin has plunged by 190% YoY
TLRY's net income has plunged by 161% YoY
The net margin has plunged by 134% YoY
Tilray's gross profit has increased by 23% YoY
Price vs fundamentals
How does TLRY's price correlate with its fundamentals
Growth
What is Tilray's growth rate over time
Valuation
What is Tilray stock price valuation
P/E
N/A
P/B
0.15
P/S
0.49
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.71
The EPS has dropped by 139% year-on-year
The price to book (P/B) is 75% lower than the 5-year quarterly average of 0.6 and 63% lower than the last 4 quarters average of 0.4
TLRY's equity is down by 21% since the previous quarter and by 19% year-on-year
TLRY's price to sales (P/S) is 87% less than its 5-year quarterly average of 3.9 and 65% less than its last 4 quarters average of 1.4
TLRY's revenue is up by 11% year-on-year
Efficiency
How efficient is Tilray business performance
The company's return on assets has shrunk by 181% YoY
The company's return on equity has shrunk by 165% YoY
The ROS has dropped by 161% year-on-year
Dividends
What is TLRY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TLRY.
Financial health
How did Tilray financials performed over time
Tilray's quick ratio has increased by 40% YoY and by 2.3% from the previous quarter
Tilray's current ratio has increased by 36% YoY and by 3.1% QoQ
The debt is 87% less than the equity
The debt has contracted by 29% YoY and by 8% from the previous quarter
TLRY's equity is down by 21% since the previous quarter and by 19% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.